AXIM® Biotechnologies Applauds Vaccine Producers, Highlights Need for Rapid Antibody Testing to Ensure Immunity

NEXT STORY
Novavax to Host Conference Call for Questions Related to Third Quarter Financial and Operating Results on November 10, 2020
PREV STORY
An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Forty Seven Inc. Reports Second Quarter 2018 Financial Results and Recent Business Highlights

-- Presented Preliminary Data from Three Clinical Trials of 5F9 as a Monotherapy and ...

author_avatar
NASDAQ Market News

Calithera Biosciences to Report First Quarter 2017 Financial Results on Tuesday, May 9, 2017

SOUTH SAN FRANCISCO, Calif., May 03, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), ...

author_avatar
NASDAQ Market News

Curetis Expands Geographic Presence with Entry into Northern African and Latin American Markets

Curetis Expands Geographic Presence with Entry into Northern African and Latin American Markets New ...

author_avatar
NASDAQ Market News